CTLA4 and central nervous system cancer: Intriguingly, other immunological indices including PD‐1, CTLA4, and IDO‐1, which are closely related to glioma progression,35 were also found to be abundantly expressed in the high‐risk score group (Figure 6C, Figure 6F, and Figure 6I).